Muhammad Bilal Abid
- Infectious Diseases top 5%
- Oncology top 10%
- Hematology top 10%
- Molecular Biology
- Epidemiology
- Co-authors
- Muhammad Abbas AbidIkram HussainParameswaran HariCalvin Jianyi KohMarcie RichesAndrew St. MartinAmer M. ZeidanLohith Gowda
- Topics
- Hematopoietic Stem Cell Transplantation (10 papers)CAR-T cell therapy research (10 papers)Multiple Myeloma Research and Treatments (7 papers)
- Journals
- The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesSingaporePakistan
In The Last Decade
Muhammad Bilal Abid
60 papers receiving 747 citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Infectious Diseases 363
- Oncology 294
- Hematology 115
- Molecular Biology 104
- Epidemiology 82
Countries citing papers authored by Muhammad Bilal Abid
This map shows the geographic impact of Muhammad Bilal Abid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Bilal Abid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Bilal Abid more than expected).
Fields of papers citing papers by Muhammad Bilal Abid
This network shows the impact of papers produced by Muhammad Bilal Abid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Bilal Abid. The network helps show where Muhammad Bilal Abid may publish in the future.
Co-authorship network of co-authors of Muhammad Bilal Abid
This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Bilal Abid. A scholar is included among the top collaborators of Muhammad Bilal Abid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Bilal Abid. Muhammad Bilal Abid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 3 | |
| 3 | 9 | |
| 4 | 9 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | 31 | |
| 8 | 21 | |
| 9 | 17 | |
| 10 | 14 | |
| 11 | 30 | |
| 12 | 4 | |
| 13 | 4 | |
| 14 | 10 | |
| 15 | 1 | |
| 16 | 9 | |
| 17 | 15 | |
| 18 | [The results of laparoscopic treatment of the gallbladder lithiasis. About 500 cases]. | 1 |
| 19 | 5 | |
| 20 | 6 |
About Muhammad Bilal Abid
Muhammad Bilal Abid is a scholar working on Microbiology, Hematology and Transplantation, having authored 68 papers that have together received 762 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (10 papers), CAR-T cell therapy research (10 papers) and Multiple Myeloma Research and Treatments (7 papers). The work is most often cited by research in Infectious Diseases (363 citations), Oncology (294 citations) and Hematology (115 citations). Muhammad Bilal Abid has collaborated with scholars based in United States, Singapore and Pakistan. Frequent co-authors include Muhammad Abbas Abid, Ikram Hussain, Parameswaran Hari, Calvin Jianyi Koh, Marcie Riches, Andrew St. Martin, Amer M. Zeidan, Lohith Gowda, Gunjan L. Shah and Roy F. Chemaly. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.